CYP cynata therapeutics limited

FY NET LOSS ATTRIBUTABLE A$14.3 MILLION VERSUS LOSS A$5.4...

  1. 16,301 Posts.
    lightbulb Created with Sketch. 6210
    • FY NET LOSS ATTRIBUTABLE A$14.3 MILLION VERSUS LOSS A$5.4 MILLION
    • FY REVENUE FROM ORDINARY ACTIVITIES A$2 MILLION VERSUS A$7.8 MILLION


    CYP finding out just how expensive it is to run trials by the looks .... @bedger they might scrape through if they get the oppies in the money but I am predicting they will undertake another CR before that - it won't take long for the GVHD trial in the USA to start to absorb what little cash they have left
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.5¢
Change
0.000(0.00%)
Mkt cap ! $37.28M
Open High Low Value Volume
17.0¢ 17.0¢ 16.0¢ $29.18K 176.1K

Buyers (Bids)

No. Vol. Price($)
2 66467 16.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 65000 1
View Market Depth
Last trade - 15.59pm 25/07/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.